AMSBIO report on a world first clinical study of iPSC-derived corneal epithelial cells by Professor Ryuhei Hayashi and co-workers from the Graduate School of Medicine, Osaka University, Japan using StemFit Basic03 clinical grade stem cell culture medium and iMatrix-511 recombinant laminin E8 fragments.
News
Cambridge, UK, and Budapest, Hungary, 31 March 2020: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing and gene modulation for cell line engineering, and Pharmahungary Group, a preclinical and clinical R&D company, today announced positive early-stage results for a novel micro-RNA therapeutic for ischemic heart diseases.
With the uncertainties around how the COVID-19 situation will develop all businesses, of course, are considering what they feel to be responsible and proportionate courses of action to take to protect themselves and others. One Nucleus is doing likewise, making these judgments in light of UK Government advice in the interests of staff, members and our wider network. To keep our contacts informed, our current view is as follows:
Whilst the disruption to business as usual continues due to the pandemic we are acutely aware that for our members maintaining their profile and network engagement is key.
We want to be sure you are aware of the ways you are still able to engage with One Nucleus. Do make the most of your membership, including via the free or discounted digital options we offer.
Events Online:
We continue to run our events online. Over the past year we have evolved the portfolio to include:
Safety equipment including masks, goggles and any kind of PPE can be donated to all hospitals and trust and better coordinated locally. In Cambridge there is coordination efforts from the University coordinating logistics between donators and NHS procurement at Addenbrooke’s Hospital. Contact Jacqui Broker, jb682@medschl.cam.ac.uk.
Further contacts:
In these unprecedented times, we at Precision remain resolute in our commitment to supporting the critical work you do. Our goal is to help you continue your cutting edge clinical research without interruption.
Cambridge, UK and Dhaka, Bangladesh, 30 March 2020: TTP plc (TTP), a leading independent technology and product development company, has today announced it has entered into a partnership with ME SOLshare Ltd (‘SOLshare’), a social enterprise that has created a new approach to distributing and trading affordable solar electricity across peer-to-peer micro-grids. By making improvements to the SOLbox trading platform, the collaboration aims to increase the supply of sustainable electrical power to communities in developing countries.
Reading Scientific Services Ltd (RSSL) has appointed David Ebdon to the newly created role of Senior Group Leader for Biological Sciences. The move comes at a time of growth and expansion for the scientific consultancy, as it continues to strengthen its position as a leading provider of analytical services to the pharmaceutical industry.
26 March 2020
UK Cambridge based technology brokerage company – Link China Pharma Solutions Helped Sareum Sign Global Licensing Deal for its FLT3+Aurora Kinase Inhibitor Programme with a China-based Specialty Pharma Company Sareum Holdings plc (AIM: SAR), the specialist cancer drug discovery and development business, is pleased to announce that it has entered into an agreement (the "Agreement") with a China-based specialty pharmaceutical company (the "Licensee).
Life Science SME's, your opportunity to share your business challenges during this turbulent time